Subject Characteristics
| Subject | PSA within ≤90 d (ng/cm3) | Gleason score at diagnosis | Total lesions measured | Prostate or prostate bed | Bones | Nodes | Viscera |
| 1 | 0.15 | 7 (4 + 5) | — | — | — | — | — |
| 2 | 4.35 | 6 (3 + 3) | 3 | 1 | — | 2 | — |
| 3 | 104.5 | 9 (4 + 5) | 15 | — | 15 | — | — |
| 4 | 0.14 | 9 (4 + 5) | 10 | 1 | 9 | — | — |
| 5 | 0.66 | 9 (5 + 4) | 4 | 1 | 2 | 1 | — |
| 6 | 0.22 | 9 (5 + 4) | 1 | — | 1 | — | — |
| 7 | 56.3 | Presumptive diagnosis | 12 | — | 12 | — | — |
| 8 | 95.5 | 7 (4 + 3) | 23 | — | 2 | 18 | 3 |
| 9 | 276.3 | 9 (4 + 5) | 15 | — | 15 | — | — |
| 10 | 0.04 | Presumptive diagnosis | — | — | — | — | — |
| 11 | 0.64 | 9 (4 + 5) | 5 | — | 5 | — | — |
| 12 | 2.8 | Lymph node biopsy | 12 | 1 | 8 | 3 | — |
| 13 | 40.1 | 10 (5 + 5) | 13 | 1 | 10 | 2 | — |
| 14 | 19.7 | 7 (3 + 4) | 2 | — | 2 | — | — |
| 15 | 2.5 | Bone biopsy | 1 | 1 | — | — | — |
| 16 | 54.1 | 9 (5 + 4) | 15 | — | 15 | — | — |
| 17 | 2.5 | 9 (5 + 4) | 2 | 1 | 1 | — | — |
| 18 | 2.5 | 9 (5 + 4) | 3 | — | 2 | 1 | — |
PSA = prostate-specific membrane antigen.